Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndromeThomas Pabst, Ulrike Bacher, Raphael Joncourt et al.|Experimental Hematology|2020Cited by 47
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 yearsAlexander D. Heini, Thomas Pabst, Urban Novak et al.|Leukemia Research|2016Cited by 27
Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacyJasmin Stettler, Thomas Pabst, Urban Novak et al.|Leukemia & lymphoma/Leukemia and lymphoma|2016Cited by 23
Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatmentSandra Keller, Thomas Pabst, Katja Seipel et al.|Leukemia Research|2015Cited by 18
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemiaDana L. Wetzel, Thomas Pabst, Beatrice U. Mueller et al.|British Journal of Haematology|2014Cited by 18